Ladenburg Thalmann Financial Services’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$545K Buy
771
+35
+5% +$24.1K ﹤0.01% 1740
2019
Q3
$472K Hold
736
﹤0.01% 1817
2019
Q2
$643K Sell
736
-28
-4% -$19.3K ﹤0.01% 1551
2019
Q1
$441K Buy
764
+156
+26% +$65.2K ﹤0.01% 1789
2018
Q4
$170K Sell
608
-5
-0.8% -$1.98K ﹤0.01% 2350
2018
Q3
$294K Buy
613
+222
+57% +$95.2K ﹤0.01% 2015
2018
Q2
$230K Hold
391
﹤0.01% 2127
2018
Q1
$230K Sell
391
-13
-3% -$8.1K ﹤0.01% 2127
2017
Q4
$251K Buy
404
+231
+134% +$166K ﹤0.01% 2049
2017
Q3
$158K Buy
173
+97
+128% +$86.2K ﹤0.01% 2274
2017
Q2
$70K Buy
76
+6
+9% +$5.88K ﹤0.01% 2771
2017
Q1
$67K Buy
70
+3
+4% +$2.79K ﹤0.01% 2680
2016
Q4
$54K Sell
67
-16
-19% -$14.4K ﹤0.01% 2793
2016
Q3
$69K Buy
83
+19
+30% +$15.3K ﹤0.01% 2525
2016
Q2
$54K Buy
64
+11
+21% +$12K ﹤0.01% 2620
2016
Q1
$60K Buy
53
+7
+15% +$7.16K ﹤0.01% 2451
2015
Q4
$58K Buy
46
+3
+7% +$4.96K ﹤0.01% 2456
2015
Q3
$59K Buy
43
+5
+13% +$8.25K ﹤0.01% 2363
2015
Q2
$69K Buy
38
+28
+280% +$43.5K ﹤0.01% 2365
2015
Q1
$16K Sell
10
-149
-94% -$221K ﹤0.01% 3334
2014
Q4
$121K Buy
+159
New +$84.4K ﹤0.01% 1775

Other funds holding TCRT

Ladenburg Thalmann Financial Services's TCRT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Alaunos Therapeutics (TCRT) stake by 4.8% in Q4 2019, buying an estimated $24.1K and bringing the position to 771 shares worth $545K. The position accounts for ﹤0.01% of the portfolio, ranked #1740.

Ladenburg Thalmann Financial Services first reported a position in TCRT in Q4 2014 and has held it in 21 quarters since. The position peaked at $643K in Q2 2019. 148 funds tracked by Wall St. Rank hold TCRT as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 771 shares of Alaunos Therapeutics worth $545K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 35 Alaunos Therapeutics shares in Q4 2019, an estimated $24.1K.
  • Alaunos Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1740 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Alaunos Therapeutics in Q4 2014 and has held it in 21 quarters since.
  • Ladenburg Thalmann Financial Services's Alaunos Therapeutics position peaked at $643K in Q2 2019.
  • 148 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.